Baiya Phytopharm Partners with KAICO through MoU on Protein Expression Services
Fukuoka, Japan, October 8, 2025 – Baiya Phytopharm (“Baiya”) is pleased to announce it has signed a Memorandum of Understanding…

October 8, 2025
Fukuoka, Japan, October 8, 2025 – Baiya Phytopharm (“Baiya”) is pleased to announce it has signed a Memorandum of Understanding…

Study Design The ongoing phase 1 trial is a dose-escalating open-label study to evaluate the Baiya SARS-CoV-2 Vax2 vaccine in…

The start-up, founded by Dr. Suthira Taychakhoonavudh and Dr. Waranyoo Phoolcharoen in 2018, has been working on a vaccine using…

“COVID-19 is not going to be the last one, right? You’re going to have so many emerging diseases and if…

Emerging infectious diseases are defined as diseases in which incidence in humans has increased in the past two decades, or…
